GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives $92.50 Consensus Target Price from Analysts

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHCGet Free Report) have earned an average recommendation of “Hold” from the fourteen ratings firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, six have given a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $92.50.

Several analysts recently weighed in on the stock. Bank of America boosted their price objective on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research note on Monday, January 5th. Morgan Stanley lifted their price objective on GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 4th. Stifel Nicolaus increased their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a research report on Wednesday, February 4th. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Finally, Barclays increased their price objective on shares of GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Friday, February 6th.

Check Out Our Latest Research Report on GE HealthCare Technologies

GE HealthCare Technologies Trading Down 3.8%

Shares of GEHC stock opened at $72.73 on Wednesday. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. The firm has a market capitalization of $33.15 billion, a P/E ratio of 15.95, a P/E/G ratio of 1.66 and a beta of 1.03. GE HealthCare Technologies has a twelve month low of $57.65 and a twelve month high of $89.77. The stock’s fifty day simple moving average is $81.44 and its 200 day simple moving average is $78.61.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last released its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period in the previous year, the business posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, sell-side analysts predict that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be given a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

Institutional Investors Weigh In On GE HealthCare Technologies

Large investors have recently added to or reduced their stakes in the business. Corient Private Wealth LLC increased its holdings in GE HealthCare Technologies by 18.7% in the fourth quarter. Corient Private Wealth LLC now owns 65,023 shares of the company’s stock worth $5,309,000 after purchasing an additional 10,226 shares in the last quarter. Auto Owners Insurance Co boosted its stake in GE HealthCare Technologies by 9,525.4% during the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after acquiring an additional 33,629,559 shares in the last quarter. Reflection Asset Management acquired a new stake in GE HealthCare Technologies in the fourth quarter worth $36,000. Strategic Investment Solutions Inc. IL increased its stake in GE HealthCare Technologies by 404.0% in the fourth quarter. Strategic Investment Solutions Inc. IL now owns 1,255 shares of the company’s stock valued at $103,000 after purchasing an additional 1,006 shares in the last quarter. Finally, MidFirst Bank acquired a new position in shares of GE HealthCare Technologies during the fourth quarter valued at about $35,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

(Get Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

See Also

Analyst Recommendations for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.